Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care

Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry

(2020) Lauren B. Cooper et al.   EUROPEAN JOURNAL OF HEART FAILURE

Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

(2020) Patrick Rossignol et al.   EUROPEAN JOURNAL OF HEART FAILURE

Reflections on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data

(2020) Camille Maringe et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Effects of hyperkalemia and non‐adherence to renin angiotensin aldosterone system inhibitors ( RAASi ) in patients affected by heart failure in Italy: a propensity‐matched study

(2020) Maurizio Volterrani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

(2020) George L. Bakris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study

(2020) Edouard L. Fu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Clinical Management of Hyperkalemia

(2020) Biff F. Palmer et al.   MAYO CLINIC PROCEEDINGS

Heart failure drug treatment

(2019) Patrick Rossignol et al.   LANCET

Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019

(2019) Biff F. Palmer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

(2019) Catherine M. Clase et al.   KIDNEY INTERNATIONAL

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality

(2019) Joost C. Beusekamp et al.   JACC-Heart Failure

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

(2018) Marco Trevisan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Is hyperkalaemia in heart failure a risk factor or a risk marker? Implications for renin-angiotensin-aldosterone system inhibitor use

(2018) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

(2018) Gianluigi Savarese et al.   EUROPEAN JOURNAL OF HEART FAILURE

Merits and caveats of propensity scores to adjust for confounding

(2018) Edouard L Fu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.

(2016) Miguel A. Hernán et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016

(2016) Murray Epstein et al.   AMERICAN JOURNAL OF MEDICINE

Trials and the ‘real world’ - how different are they?

(2016) John J. V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database

(2016) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

(2016) Miguel A. Hernán et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Association of Spironolactone Use With All-Cause Mortality in Heart Failure

(2013) Lars H. Lund et al.   Circulation-Heart Failure

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy

(2013) Patrick Rossignol et al.   Circulation-Heart Failure

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care

(2013) Anne Gjesing et al.   EUROPEAN JOURNAL OF HEART FAILURE

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

(2013) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 ACCF/AHA Guideline for the Management of Heart Failure

(2013) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction

(2012) Adrian F. Hernandez et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions

(2010) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Negative Controls

(2010) Marc Lipsitch et al.   EPIDEMIOLOGY

When to Start Treatment? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data

(2010) Lauren E. Cain et al.  

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE